# Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis

> **NCT02242071** · PHASE1 · WITHDRAWN · sponsor: **Neurogen Brain and Spine Institute**

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **BIOLOGICAL:** Stem Cell

## Key facts

- **NCT ID:** NCT02242071
- **Lead sponsor:** Neurogen Brain and Spine Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-12
- **Primary completion:** 2015-03
- **Final completion:** 2016-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242071, "Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02242071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*